ADMdx

Turning images into insights

Menu
  • Home
  • About us
    • About ADMdx
    • Management team
    • Collaborations
  • Clinical trials
    • Capabilities
    • Subject inclusion
    • Enrichment and stratification
    • Detecting treatment effect
    • Data insight for planning & discovery
    • Our technology
  • Diagnostics
    • Overview
    • Dementia diagnostics
    • About dementias
    • About imaging
  • Publications
  • Contact
  • News

ADMdx to present results of dementia differentiation using MRI, FDG, and early frame amyloid imaging at AAIC

July 13, 2018 By ADMdx

ADMdx will present the results of machine learning classification of different Alzheimer’s disease variants and non Alzheimer’s dementias using three different modalities:  structural MRI, glucose metabolism using FDG PET, and early timeframes of amyloid PET scans.  This work was conducted in collaboration with researchers from the Memory and Aging Center of the University of California, San Francisco. The research will be presented orally on July 25th at the Alzheimer’s Association International Conference in Chicago.

Filed Under: News

Copyright © 2021 ADM Diagnostics, Inc.